W
WAVEMAN · COMPANY
TXG · 10X Genomics, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

TXG

10x Genomics, Inc.
MEDICAL DEVICES · LABORATORY ANALYTICAL INSTRUMENTS · CIK 0001770787
FORM 144 · 9☆ WATCH
INSIDER NET · 180D
-$8.5M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
203
13F, latest reported quarter
REVENUE GROWTH
+5.2%
XBRL, annual
NET MARGIN
-6.8%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$8.5M over 180 days
-$6.7M over 90 days
below 84% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
203 funds added or opened last quarter
more than 77% of Medical Devices
REVENUE
+5.2% year over year
below 59% of Medical Devices
MARGIN
-6.8% net margin
more than 54% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$8.5M across 6 people in 180 days.
203 funds added or opened positions in the latest 13F quarter, of 394 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +368.6%
+368.6%12M
-15%+119%+253%+387%2025-092025-102025-122026-032026-052026-072026-09 2026-08-24 · Saxonov Serge sold $1.2M2026-08-24 · Taich Adam sold $1.1M2026-08-11 · STUELPNAGEL JOHN R sold $978.9K2026-08-24 · Hindson Benjamin J. sold $870.9K2026-05-22 · Saxonov Serge sold $444.2K2026-08-26 · Saxonov Serge sold $415.5K2026-05-22 · Taich Adam sold $369.0K2026-06-22 · Saxonov Serge sold $346.9K2026-06-22 · Saxonov Serge sold $342.5K2026-03-02 · Saxonov Serge sold $324.0K2026-08-13 · Teichmann Sarah A. sold $302.4K2026-06-22 · Saxonov Serge sold $283.9K2026-05-22 · Hindson Benjamin J. sold $283.4K2026-05-26 · Saxonov Serge sold $264.8K2025-11-24 · Saxonov Serge sold $252.0K2025-11-24 · Taich Adam sold $225.9K2026-08-26 · Saxonov Serge sold $220.6K2026-03-23 · Saxonov Serge sold $191.3K2026-02-23 · Saxonov Serge sold $179.0K2026-08-11 · STUELPNAGEL JOHN R sold $176.2K2026-06-16 · SULIMAN SHEHNAAZ sold $174.6K2026-02-23 · Taich Adam sold $166.6K2025-11-24 · Hindson Benjamin J. sold $157.4K2026-02-25 · Teichmann Sarah A. sold $147.1K2026-02-23 · Hindson Benjamin J. sold $145.4K2026-08-14 · Teichmann Sarah A. sold $129.9K2026-04-14 · Saxonov Serge sold $122.8K2026-08-24 · SULIMAN SHEHNAAZ sold $105.3K2026-03-24 · Saxonov Serge sold $97.6K2026-06-22 · Saxonov Serge sold $60.1K2026-03-02 · Saxonov Serge sold $43.1K2026-08-24 · SULIMAN SHEHNAAZ sold $35.2K2026-08-26 · Saxonov Serge sold $31.9K2026-06-16 · SULIMAN SHEHNAAZ sold $12.1K2026-09-03 · STUELPNAGEL JOHN R filed to sell $1.2M2026-08-26 · Serge Saxonov filed to sell $2.2M2026-08-24 · Hindson Benjamin J. filed to sell $870.8K2026-08-24 · Saxonov Serge filed to sell $1.2M2026-08-24 · Shehnaaz Suliman filed to sell $143.7K2026-08-24 · Taich Adam filed to sell $1.1M2026-08-14 · SARAH A POLONIUS-TEICHMANN filed to sell $129.9K2026-08-13 · SARAH A POLONIUS-TEICHMANN filed to sell $302.4K2026-08-11 · STUELPNAGEL JOHN R filed to sell $1.2M
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $8.5M sold by insiders over 180 days, 203 funds added last quarter, $8.3M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
TMOPENROKBLFSMTDSIBNWRBYISRGDXCMEWTMDXITRI
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, 10x Genomics, Inc. insiders sold a net $8.5M of stock across 397 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Saxonov Serge
Chief Executive Officer
SELL
2026-08-26
3,500.0
$220.6K
Saxonov Serge
Chief Executive Officer
SELL
2026-08-26
6,494.0
$415.5K
Saxonov Serge
Chief Executive Officer
SELL
2026-08-26
492.0
$31.9K
SULIMAN SHEHNAAZ
Director
SELL
2026-08-24
561.0
$35.2K
SULIMAN SHEHNAAZ
Director
SELL
2026-08-24
1,646.0
$105.3K
397 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 392 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
FMR LLC
17,629,266.0 sh
$675.9M
BlackRock, Inc.
10,804,070.0 sh
$414.2M
ARK Investment Management LLC
10,003,057.0 sh
$383.5M
VANGUARD PORTFOLIO MANAGEMENT LLC
6,982,492.0 sh
$267.7M
Quantinno Capital Management LP
5,469,698.0 sh
$209.7M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
STUELPNAGEL JOHN R
FILED 2026-09-03
$1.2M
Serge Saxonov
FILED 2026-08-26
$2.2M
Hindson Benjamin J.
FILED 2026-08-24
$870.8K
Saxonov Serge
FILED 2026-08-24
$1.2M
Shehnaaz Suliman
FILED 2026-08-24
$143.7K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
ARK Genomic Revolution ETF
$71.3M POSITION · AS OF 2026-04-30
5.8%
Simplify Health Care ETF
$7.6M POSITION · AS OF 2026-03-31
3.2%
American Beacon ARK Transformational Innovation Fund
$3.9M POSITION · AS OF 2026-03-31
2.5%
ARK Innovation ETF
$149.6M POSITION · AS OF 2026-04-30
2.3%
Global X Genomics & Biotechnology ETF
$1.1M POSITION · AS OF 2026-02-28
2.2%
Fidelity Disruptive Medicine ETF
$1.0M POSITION · AS OF 2026-02-28
1.7%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Serge Saxonov
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$6.3M
$6.8M
$2.8M
-88%
+25%
2024
$7.9M
-$21.2M
$4.4M
-90%
-7%
2023
$8.3M
$17.3M
$3.4M
-60%
-6%
2022
$18.8M
-$14.3M
$9.4M
-74%
-10%
2021
$11.7M
$20.8M
$5.0M
+5%
+0%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$642.8M$610.8M$618.7M$516.4M
GROSS PROFIT$443.9M$414.5M$409.3M$396.0M
OPERATING INCOME$-61.0M$-194.6M$-265.3M$-167.9M
NET INCOME$-43.5M$-182.6M$-255.1M$-166.0M
EPS (DILUTED)-0.35-1.52-2.18-1.46
OPERATING CASH FLOW$136.1M$6.7M$-15.2M$-33.6M
CASH—$344.1M$359.3M$219.7M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →